Dear All,
We are pleased to announce that Amylum Korea has successfully executed its second investment agreement with a Korean venture capital partner.
Also, the VC has aligned to make an additional investment of KRW 10 billion by late this year or early next year.
This capital will support the establishment of a second manufacturing facility in Busan, at a scale comparable to the existing plant, to strategically serve both the Korean and Japanese markets.
This milestone will represent a significant step forward for Amylum Korea, as it:
- Establishes a strategic production hub for Korea and Japan
- Accelerates planned revenue growth, and
- Provides a strong foundation toward our targeted IPO in Korea by 2028
With this development, Amylum Korea is now positioned for sustained and scalable growth.
Looking ahead, our next strategic priority is to secure funding for Amylum USA and replicate this manufacturing capability in the U.S. market.
By establishing a production platform equivalent to Amylum Korea, we are targeting a U.S. public listing around 2030, completing our global expansion roadmap.
We sincerely appreciate your continued support and partnership as we move forward on this journey, and we look forward to building this milestone together.
Sincerely,
